Literature DB >> 19321223

Smoking cessation is challenging even for patients recovering from lung cancer surgery with curative intent.

Mary E Cooley1, Linda Sarna, Jenny Kotlerman, Jeanne M Lukanich, Michael Jaklitsch, Sarah B Green, Raphael Bueno.   

Abstract

BACKGROUND: Although it is recommended that smokers undergoing surgery for lung cancer quit smoking to reduce post-operative complications, few studies have examined patterns of smoking in the peri-operative period. The goals of this study were to determine: (1) patterns of smoking during post-operative recovery, (2) types of cessation strategies used to quit smoking, and (3) factors related to smoking after lung cancer surgery.
METHODS: Data were collected from 94 patients through chart review, tobacco, health status, and symptom questionnaires at 1, 2, and 4 months after surgery. Smoking status was assessed through self-report and urinary cotinine measurement.
RESULTS: Eighty-four patients (89%) were ever-smokers and 35 (37%) reported smoking at diagnosis. Thirty-nine (46%) ever-smokers remained abstinent, 13 (16%) continued smoking at all time-points, and 32 (38%) relapsed. Ten (46%) of those who relapsed were former-smokers and had not smoked for at least 1 year. Sixteen (46%) of those who were smoking at diagnosis received cessation assistance with pharmacotherapy being the most common strategy. Factors associated with smoking during recovery were younger age and quitting smoking < or =6 months before the diagnosis of lung cancer. Factors that were marginally significant were lower educational level, male gender, lower number of comorbidities, and the presence of pain.
CONCLUSION: Only half of those who were smoking received assistance to quit prior to surgery. Some patients were unable to quit and relapse rates post-surgery were high even among those who quit more than 1 year prior. Innovative programs incorporating symptom management and relapse prevention may enhance smoking abstinence during post-operative care.

Entities:  

Mesh:

Year:  2009        PMID: 19321223      PMCID: PMC3805262          DOI: 10.1016/j.lungcan.2009.01.021

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  48 in total

1.  What accounts for the association of education and smoking cessation?

Authors:  David W Wetter; Ludmila Cofta-Gunn; Jennifer E Irvin; Rachel T Fouladi; Kelli Wright; Patricia Daza; Carlos Mazas; Paul M Cinciripini; Ellen R Gritz
Journal:  Prev Med       Date:  2005-04       Impact factor: 4.018

2.  Clarification of SRNT workgroup guidelines for measures in clinical trials of smoking cessation therapies.

Authors:  John R Hughes; Neal Benowitz; Dorothy Hatsukami; Robin J Mermelstein; Saul Shiffman
Journal:  Nicotine Tob Res       Date:  2004-10       Impact factor: 4.244

3.  The diagnosis of a smoking-related disease is a prominent trigger for smoking cessation in a retrospective cohort study.

Authors:  Dorothee Twardella; Michael Loew; Dietrich Rothenbacher; Christa Stegmaier; Hartwig Ziegler; Hermann Brenner
Journal:  J Clin Epidemiol       Date:  2005-10-13       Impact factor: 6.437

4.  Promoting repeat tobacco dependence treatment: are relapsed smokers interested?

Authors:  Steven S Fu; Melissa R Partin; Annamay Snyder; Lawrence C An; David B Nelson; Barbara Clothier; Sean Nugent; Mark L Willenbring; Anne M Joseph
Journal:  Am J Manag Care       Date:  2006-04       Impact factor: 2.229

5.  Second hand smoke exposure and survival in early-stage non-small-cell lung cancer patients.

Authors:  Wei Zhou; Rebecca S Heist; Geoffrey Liu; Kofi Asomaning; David P Miller; Donna S Neuberg; John C Wain; Thomas J Lynch; David C Christiani
Journal:  Clin Cancer Res       Date:  2006-12-01       Impact factor: 12.531

6.  Prognostic value of smoking status in operated non-small cell lung cancer.

Authors:  Peyman Sardari Nia; Joost Weyler; Cecile Colpaert; Peter Vermeulen; Eric Van Marck; Paul Van Schil
Journal:  Lung Cancer       Date:  2005-03       Impact factor: 5.705

7.  Preoperative smoking habits and postoperative pulmonary complications.

Authors:  L G Bluman; L Mosca; N Newman; D G Simon
Journal:  Chest       Date:  1998-04       Impact factor: 9.410

8.  The Schwartz Cancer Fatigue Scale: testing reliability and validity.

Authors:  A L Schwartz
Journal:  Oncol Nurs Forum       Date:  1998-05       Impact factor: 2.172

9.  Quality of life and meaning of illness of women with lung cancer.

Authors:  Linda Sarna; Jean K Brown; Mary E Cooley; Roma D Williams; Cynthia Chernecky; Geraldine Padilla; Leda Layo Danao
Journal:  Oncol Nurs Forum       Date:  2005-01-19       Impact factor: 2.172

10.  State- and sex-specific prevalence of selected characteristics--Behavioral Risk Factor Surveillance System, 1996 and 1997.

Authors:  D Holtzman; E Powell-Griner; J C Bolen; L Rhodes
Journal:  MMWR CDC Surveill Summ       Date:  2000-07-07
View more
  44 in total

1.  A snapshot of smokers after lung and colorectal cancer diagnosis.

Authors:  Elyse R Park; Sandra J Japuntich; Nancy A Rigotti; Lara Traeger; Yulei He; Robert B Wallace; Jennifer L Malin; Jennifer P Zallen; Nancy L Keating
Journal:  Cancer       Date:  2012-01-23       Impact factor: 6.860

2.  Incidence of metachronous second primary cancers in Osaka, Japan: update of analyses using population-based cancer registry data.

Authors:  Takahiro Tabuchi; Yuri Ito; Akiko Ioka; Isao Miyashiro; Hideaki Tsukuma
Journal:  Cancer Sci       Date:  2012-04-11       Impact factor: 6.716

3.  Post-operative smoking status in lung and head and neck cancer patients: association with depressive symptomatology, pain, and fatigue.

Authors:  Erika Litvin Bloom; Jason A Oliver; Steven K Sutton; Thomas H Brandon; Paul B Jacobsen; Vani Nath Simmons
Journal:  Psychooncology       Date:  2014-09-25       Impact factor: 3.894

4.  Smoking status, service use and associated factors among Japanese cancer survivors--a web-based survey.

Authors:  Daisuke Fujisawa; Shino Umezawa; Ado Basaki-Tange; Maiko Fujimori; Mitsunori Miyashita
Journal:  Support Care Cancer       Date:  2014-05-22       Impact factor: 3.603

5.  Cigarette smoke extract stimulates epithelial-mesenchymal transition through Src activation.

Authors:  Hongqiao Zhang; Honglei Liu; Zea Borok; Kelvin J A Davies; Fulvio Ursini; Henry Jay Forman
Journal:  Free Radic Biol Med       Date:  2012-02-04       Impact factor: 7.376

Review 6.  Integration of tobacco cessation services into multidisciplinary lung cancer care: rationale, state of the art, and future directions.

Authors:  Graham W Warren; Kenneth D Ward
Journal:  Transl Lung Cancer Res       Date:  2015-08

7.  Smoking status and pain level among head and neck cancer patients.

Authors:  Henrietta L Logan; Roger B Fillingim; Linda M Bartoshuk; Pamela Sandow; Scott L Tomar; John W Werning; William M Mendenhall
Journal:  J Pain       Date:  2009-12-16       Impact factor: 5.820

Review 8.  Systematic Review of Tobacco Use after Lung or Head/Neck Cancer Diagnosis: Results and Recommendations for Future Research.

Authors:  Jessica L Burris; Jamie L Studts; Antonio P DeRosa; Jamie S Ostroff
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-08-17       Impact factor: 4.254

9.  Smoking relapse-prevention intervention for cancer patients: Study design and baseline data from the surviving SmokeFree randomized controlled trial.

Authors:  Diana B Díaz; Thomas H Brandon; Steven K Sutton; Lauren R Meltzer; Hannah J Hoehn; Cathy D Meade; Paul B Jacobsen; Judith C McCaffrey; Eric B Haura; Hui-Yi Lin; Vani N Simmons
Journal:  Contemp Clin Trials       Date:  2016-07-25       Impact factor: 2.226

10.  Tobacco use in the oncology setting: advancing clinical practice and research.

Authors:  Ellen R Gritz; Benjamin A Toll; Graham W Warren
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-01       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.